Published in Gynecol Oncol on October 04, 2007
Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study). Gut (2009) 5.08
Conservation. Challenges to the future conservation of the Antarctic. Science (2012) 3.01
Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res (2000) 2.83
The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy (2005) 2.49
Human ovarian tissue cryopreservation: quality of follicles as a criteria of effectiveness. Reprod Biomed Online (2010) 2.46
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995) 1.84
[Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol (2008) 1.81
Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med (1993) 1.80
The structure of cat muscle pyruvate kinase. EMBO J (1986) 1.74
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol (2002) 1.72
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. J Clin Oncol (2004) 1.70
Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol (1994) 1.61
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res (2001) 1.59
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol (1999) 1.58
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol (2005) 1.58
[S3-guideline colorectal cancer version 1.0]. Z Gastroenterol (2013) 1.51
Secretion of cellulase and beta-glucosidase by Trichoderma viride ITCC-1433 in submerged culture on different substrates. Biotechnol Bioeng (1979) 1.45
Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat (2000) 1.45
p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45
Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation. Reproduction (2009) 1.42
[Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer]. Geburtshilfe Frauenheilkd (1993) 1.39
[Diabetes screening in pregnant patients with different risk factors. Benefits, therapeutic success, consequences]. Z Geburtshilfe Neonatol (1996) 1.39
Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol (2001) 1.34
Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol (2009) 1.33
Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol (2002) 1.32
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics (2001) 1.23
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med (2001) 1.22
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol (2001) 1.17
An improved TnMax mini-transposon system suitable for sequencing, shuttle mutagenesis and gene fusions. Gene (1995) 1.15
Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology (1995) 1.14
Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat (2013) 1.14
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat (2010) 1.13
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res (1998) 1.13
Hemicellulose-degrading bacteria and yeasts from the termite gut. J Appl Bacteriol (1996) 1.12
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44). Ann Oncol (2013) 1.09
MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol (1997) 1.08
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines. Int J Cancer (1992) 1.08
Sequence of Escherichia coli D-serine dehydratase. Location of the pyridoxal-phosphate binding site. FEBS Lett (1981) 1.06
Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology (2000) 1.06
Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecol Oncol (2008) 1.05
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer (2000) 1.04
Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension (1993) 1.03
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer (1999) 1.03
Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study. Breast Cancer Res Treat (2011) 1.01
Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol (2000) 1.01
Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells. Reproduction (2008) 1.01
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group. J Clin Oncol (1989) 1.00
Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol (2005) 1.00
Ischaemic colitis in a patient treated with glypressin for bleeding oesophageal varices. Hepatogastroenterology (1987) 1.00
Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification. Br J Cancer (2005) 1.00
Long-term results after operative correction of vaginal aplasia. Am J Obstet Gynecol (1996) 0.98
Pediatric generalists and subspecialists: determinants of career satisfaction. Pediatrics (2001) 0.98
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial. Ann Oncol (2010) 0.98
Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol (2004) 0.98
A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol Lett (1997) 0.95
A comparison of international breast cancer guidelines - do the national guidelines differ in treatment recommendations? Eur J Cancer (2011) 0.94
Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol (2000) 0.94
p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells. Oncology (1999) 0.94
Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol (1998) 0.94
Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant (2001) 0.93
Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin. Int J Cancer (1998) 0.93
Spatio-temporal source imaging reveals subcomponents of the human auditory mismatch negativity in the cingulum and right inferior temporal gyrus. Neurosci Lett (2001) 0.93
25-hydroxy-vitamin-D in nephrotic syndrome. Lancet (1977) 0.92
A multiplex one-step real-time RT-PCR assay for influenza surveillance. Euro Surveill (2011) 0.92
[Immunological and electrophoretic characterization of flagellins of different H-types of Pseudomonas aeruginosa (author's transl)]. Med Microbiol Immunol (1980) 0.92
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy. Ann Oncol (2013) 0.92
Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk? Br J Radiol (2002) 0.90
Microangiopathic haemolytic anaemia associated with hypercalcaemia in an experimental rat tumour. Br J Haematol (1973) 0.90
Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat. Horm Metab Res (1970) 0.89
[Stage 3 recommendations--the early recognition of breast cancer in Germany. Abridged version for medical practitioners]. Radiologe (2003) 0.88
Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle. Breast Cancer Res Treat (2011) 0.88
Angiogenesis in the primate ovary. Reprod Fertil Dev (2001) 0.88
Ultrasound assessment of tension-free vaginal tape (TVT). Ultraschall Med (2010) 0.87
Investigation of infectious organisms causing pericoronitis of the mandibular third molar. J Oral Maxillofac Surg (2000) 0.87
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines. Gynecol Oncol (1993) 0.86
Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study. Gynecol Oncol (1998) 0.86
[Blue rubber-bleb nevus syndrome and therapeutic double balloon enteroscopy]. Z Gastroenterol (2006) 0.86
Development of a duplex real-time PCR for differentiation between E. coli and Shigella spp. J Appl Microbiol (2011) 0.86
Acrosomal status and mitochondrial activity of human spermatozoa vitrified with sucrose. Reproduction (2008) 0.85
Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer. Br J Cancer (2002) 0.85
Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr (1997) 0.85
Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. Anticancer Res (1997) 0.85
Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial. Eur J Surg Oncol (2008) 0.85
[The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma]. Rofo (1996) 0.84
[Hypercalcemic activity of Walker carcinosarcoma 256 in the rat]. Schweiz Med Wochenschr (1971) 0.84
Regulation of tight junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor. Mol Hum Reprod (2007) 0.84
Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation. Gynecol Oncol (2001) 0.84
Subcellular localization of accumulated p53 in ovarian cancer cells. Gynecol Oncol (1996) 0.84